Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$137.78−5.59 (-3.90%)
Close on Nov 18, 2026Market cap $339.93BP/E 110.2Yield 2.38%
Merck market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Merck's market cap was $367.39B on Nov 10, 2026, against $264.09B a year earlier. Over the last 5 years it ranged from $194.36B to $371.03B, with a median of $270.44B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $367.39B | +38.5% |
| 2025 | Dec 31, 2025 | $265.18B | +4.8% |
| 2024 | Dec 31, 2024 | $252.93B | -8.9% |
| 2023 | Dec 29, 2023 | $277.56B | -1.4% |
| 2022 | Dec 30, 2022 | $281.65B | +44.7% |
| 2021 | Dec 31, 2021 | $194.63B | -6.5% |
| 2020 | Dec 31, 2020 | $208.18B | -11.9% |
| 2019 | Dec 31, 2019 | $236.40B | +14.4% |
| 2018 | Dec 31, 2018 | $206.57B | +33.3% |
| 2017 | Dec 29, 2017 | $155.02B | -5.8% |
| 2016 | Dec 30, 2016 | $164.60B | +9.0% |
| 2015 | Dec 31, 2015 | $151.03B | -11.2% |
| 2014 | Dec 31, 2014 | $170.14B | +11.8% |
| 2013 | Dec 31, 2013 | $152.23B | +21.0% |
| 2012 | Dec 31, 2012 | $125.84B | +25.1% |
| 2011 | Jan 31, 2011 | $100.57B | -8.0% |
| 2010 | Dec 31, 2010 | $109.28B | – |
See a number that looks wrong?